It revealed that CNOT3 depletion enhanced the anti-tumor effect of gefitinib in PC-9 GR cells as long as we prolonged treatment (Fig. 5J, K and Supplementary Fig. 6). This evidence concerns the gene CNOT3 and neoplasm.